Hospital lobbying groups say they’re hearing President Donald Trump may be backing off plans to scale back a federal program that requires drugmakers to give discounted products to hospitals that treat a high number of poor patients.

Read More: http://www.modernhealthcare.com/article/20170712/NEWS/170719964

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields